Note: The U.S. Food and Drug Administration (FDA) does not approve supplements for safety or effectiveness. Talk to a healthcare professional about whether a supplement is the right fit for your ...

HPT, HP, and HK in the 7MM and a moderate sales growth forecast highlight market opportunities. Significant unmet needs and emerging pipeline products present avenues for market expansion and ...

Data from the SMART-C show that SGLT2i use reduces kidney disease progression risk in patients with type 2 diabetes, CKD, or heart failure, across the full spectrum of kidney function and albuminuria.

Of the 499,997 people with complete data, 93,406 (18.7%) had at least one eGFR < 60 ml/min/1.73 m 2. Only a small number of those (6044, 6.5%) had no further eGFR testing (Figure 2). We identified ...

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — A study into Medicare beneficiaries with stage 3-5 chronic kidney disease suggests that an ...

Science Progress (1933-), Vol. 104, No. 2 (2021), pp. 1-27 (27 pages) The complexity of chronic kidney disease (CKD) and its treatments have made self-management behaviors inevitably challenging.